Exchange: NASDAQ·Updated 05:16 PM EDT
JSPR logo

JSPR Jasper Therapeutics Inc

$0.57
$0.0163
(2.57%)
Today
Closed $0.6178
$0.0478
(7.74%)
After Hours
EarningsNov 10
Mkt Cap$20.56M
Vol222,807.00

About JSPR

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
54

Neutral Sentiment

How do you feel about JSPR?

Advertisement|Remove ads.